Advisorshares Vice ETF (ACT)
$22.89 0.00 (0.00%)
16:00 EDT ACT Stock Quote Delayed 30 Minutes
Previous Close $22.89
Market Cap -
PE Ratio -
Volume (Avg. Vol.)
Day's Range 22.89 - 22.89
52-Week Range 16.16 - 25.85
Dividend & Yield 0.05 (0.20%)
ACT Stock Predictions, Articles, and Advisorshares Vice ETF News
- From InvestorPlace
- From the Web
The landscape for best ETFs in 2020 has changed after the novel coronavirus pandemic with technology and cloud companies leading the bunch.
With the healthcare and alcohol sectors currently carrying ACT through 2020, ACT might improve its ranking in the Best ETFs contest later down the road.
While some might overlook the vice stocks theme, there are reasons to take a closer look. Here are the best vice ETFs to buy.
It's difficult to find the ETFs to buy amidst a crisis such as the coronavirus outbreak. But some investment themes are more conducive to a comeback than others.
In a time of world-wide quarantine brought on by the coronavirus, some of the ACT ETF’s holdings might actually withstand the turmoil and widespread isolation.
Choosing the best ETF in 2020 won't be easy, but many of these funds stand a chance at being among the best ETFs to buy for next year.
The ACT ETF has long-term durability with concentrated exposure to select companies related to alcohol, cannabis and tobacco.
Marijuana stocks could be great long-term investments. However, they are still a risky bet. These marijuana ETFs make owning them a little less dangerous.
Despite talk of overvaluation, there are some consumer staples ETFs that can deliver more exciting returns to the normally sleepy sector.
The universe of U.S. marijuana ETFs is sparsely populated. Right now, these marijuana ETFs are the only two that U.S. investors need consider.
Marijuana ETFs may still be few and far between, but these three are more than enough to get regular investors safely into the game.
Despite their potential for profit, the U.S. has a real lack of marijuana ETFs. Here are 3 funds to get you some marijuana exposure while the market catches up.
In the world of ETFs, the most widely anticipated products are those related to cryptocurrencies and marijuana stocks. Investors will be waiting awhile for digital currency ETFs as regulators recently rebuffed plans for such funds. Fortunately, marijuana ETFs are not encountering the same resistance.
Some of the best ETFs to buy focus either on the light or dark sides of the market. Here's what investors should know about ETFs that focus on socially responsible stocks and sin stocks.
Healthcare stocks rose broadly on Wall Street today, with the sector seeing an overall increase of 1.2%.
Healthcare stocks finished flat on Thursday on Wall Street.
A new batch of 13Fs has given us insight into what Wall Street's "smart money" thought was worth buying and selling in Q1. Here are some of the best ideas from the group.
Healthcare stocks rose 0.2% on Wall Street so far on Monday.
From Analyst Ratings
Analysts have been eager to weigh in on the Financial sector with new ratings on BBX Capital (BBX – Research Report) and Progressive (PGR – Research Report). BBX Capital (BBX) In a report released today, Mike Crawford from B.Riley FBR maintained a Buy rating on BBX Capital, with a price target of $7.00. The company’s